Celularity (CELU) EBITDA Margin (2020 - 2026)
Celularity (CELU) posted EBITDA Margin of -493.54% for Q4 2025, down 452.71 percentage points from -40.83% a year earlier and down 283.93 percentage points from the prior quarter.
Powered by 
Analysis
Celularity (CELU) EBITDA Margin (2020 - 2026) Analysis & Trends
For FY2025, Celularity's EBITDA Margin came in at -203.44%, down 147.30 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +803.36 percentage points (FY2020 to FY2025).
- In prior years, Celularity's EBITDA Margin was -56.13% in FY2024 (+747.36 pp), -803.49% in FY2023 (-713.57 pp), -89.92% in FY2022 (+379.92 pp) and -469.85% in FY2021 (+536.95 pp).
- The Q4 2025 figure stands as the lowest quarterly EBITDA Margin since Q3 2023.
- On a year-over-year basis, EBITDA Margin has declined in each of the last five quarters, with an average year-over-year change of +542.15 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q3 2024, with a gain of 2456.15 percentage points; the weakest was Q3 2023, with a drop of 2481.13 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -209.61% (Q3 2025), -244.60% (Q2 2025) and -75.72% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Celularity | 39.39 Mn | 31.87 Mn | 2.39 Mn | -221.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -221.94% |
| Dec 31, 2025 | -493.54% |
| Sep 30, 2025 | -209.61% |
| Jun 30, 2025 | -244.60% |
| Mar 31, 2025 | -75.72% |
| Dec 31, 2024 | -40.83% |
| Sep 30, 2024 | -103.63% |
| Jun 30, 2024 | -67.53% |
| Mar 31, 2024 | -35.56% |
| Dec 31, 2023 | 128.89% |
| Sep 30, 2023 | -2,559.77% |
| Jun 30, 2023 | -1,366.71% |
| Mar 31, 2023 | -1,563.07% |
| Dec 31, 2022 | 482.54% |
| Sep 30, 2022 | -78.65% |
| Jun 30, 2022 | 171.98% |
| Mar 31, 2022 | -662.68% |
| Dec 31, 2021 | -254.22% |
| Sep 30, 2021 | 124.67% |
| Jun 30, 2021 | -1,835.47% |
API Access
Celularity EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();